Research Projects & Grants

For Profit Organization

  • A Phase 2/3 Randomized, Placebo-Controlled, Double-blind, Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants with Heart Failure due to Systemic Left Ventricular Systolic Dysfunction (VALOR), Role: Investigator, Merck, (03/2025 - 03/2026) Status: Approved
  • A multi-center, double-blind, placebo-controlled, dose-titration study evaluating the efficacy, safety, pharmacodynamics and pharmacokinetics of oxybutynin chloride topical gel for the treatment of detrusor overactivity associated with a neurological condition in pediatric subjects, Role: Investigator, Watson Laboratories, Inc., (12/2021 - 12/2022) Status: Completed
  • Humanitarian Use Device: Medtronic melody transcatheter pulmonary valve and Medtronic ensemble transcatheter valve delivery system, Role: Investigator, Medtronic, Inc., (09/2014 - 09/2015) Status: Completed
  • A pilot study of the renal and systemic hemodynamic effects of nesiritide (human recombinant B-type natriuretic peptide) delivered via bilateral intra-renal infusion in patients with cardiac transplant, Role: Investigator, Flow Medica, Inc., (03/2005 - 03/2006) Status: Completed
  • Percutaneous transluminal valvuloplasty catheter study, Role: PI, NuMed Inc., (03/2000 - 03/2001) Status: Completed
  • NuMED Atrioseptostomy Balloon Catheter Clinical Study, Role: PI, NuMed Inc., (08/1995 - 08/1996) Status: Completed

Internal

  • Pediatric heart transplant study group collaborative database, Role: PI, LLU Dept. of Pediatrics, (03/2025 - 03/2026) Status: Approved
  • Epstein-Barr viremia treatment with oral valganciclovir and intravenous immune globulin in pediatric cardiac transplant patients, Role: PI, LLU Dept. of Pediatrics, (08/2021) Status: Approved
  • Advanced cardiac therapies improving outcomes network to improve the health of pediatric and congenital heart disease patients with heart failure, Role: Investigator, LLU Dept. of Pediatrics, (12/2019) Status: Approved
  • Compassionate use: Covered Cheatham platinum stents, Role: Investigator, LLU Dept. of Pediatrics, (11/2015 - 11/2016) Status: Completed
  • Changes on B-type natriuretic peptide as a biomarker for graft performance after heart transplantation in pediatric patients, Role: PI, LLU Dept. of Pediatrics, (05/2015) Status: Completed
  • Utility of pre-procedure checklists in the cardiac catheterization laboratory, Role: Investigator, LLU Dept. of Pediatrics, (02/2012) Status: Completed
  • Association of prominent corticomedullary veins on susceptibility weighed magnetic resonance images with physiologic factors stemming from cyanotic heart disease, Role: Investigator, LLU Dept. of Radiology, (08/2009 - 08/2010) Status: Completed
  • Effectiveness of ultrasound cardiac output monitoring device in screening for acute graft rejection in patients with orthotopic cardiac transplantation, Role: Investigator, LLU Dept. of Pediatrics, (04/2007 - 04/2008) Status: Completed
  • The diagnosis of chronic allograft rejection in pediatric heart transplant recipients by intravascular ultrasound, Role: PI, Loma Linda University Medical Center, (12/1997 - 12/1998) Status: Completed
  • Emergency Use: Gore-Tex covered stent, Role: PI, LLU Dept. of Pediatrics, Status: Approved

Non-Profit Organization

  • Pulmonary artery repair with covered stents (PARCS): The use of covered Cheatham Platinum® stents for repair of right ventricular to pulmonary artery conduits disruption during preparation for implantation of the Melody® transcatheter pulmonary valve, Role: Investigator, John Hopkins Hospital, (02/2016 - 02/2017) Status: Completed